Evidence map›Paper›PMID 34634078›Full record

ArticlePloS one2021

Flatten the curve: Empirical evidence on how non-pharmaceutical interventions substituted pharmaceutical treatments during COVID-19 pandemic.

Weiyu Luo, Wei Guo, Songhua Hu, Mofeng Yang, Xinyuan Hu, Chenfeng Xiong

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.4field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Weiyu LuoMaryland Transportation Institute (MTI), Department of Civil and Environmental Engineering, University of Maryland, College Park, MD, United States of America.ORCID 0000-0002-7987-2199
Wei GuoAsia-Pacific Academy of Economics and Management and Faculty of Business Administration, University of Macau, Macau, China.
Songhua HuMaryland Transportation Institute (MTI), Department of Civil and Environmental Engineering, University of Maryland, College Park, MD, United States of America.
Mofeng YangMaryland Transportation Institute (MTI), Department of Civil and Environmental Engineering, University of Maryland, College Park, MD, United States of America.
Xinyuan HuMaryland Transportation Institute (MTI), Department of Civil and Environmental Engineering, University of Maryland, College Park, MD, United States of America.
Chenfeng XiongMaryland Transportation Institute (MTI), Department of Civil and Environmental Engineering, University of Maryland, College Park, MD, United States of America.ORCID 0000-0003-4237-1750
University of Maryland, College Park · USUniversity of Macau · MOUniversity of Maryland, Baltimore · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

During the outbreak of the COVID-19 pandemic, Non-Pharmaceutical and Pharmaceutical treatments were alternative strategies for governments to intervene. Though many of these intervention methods proved to be effective to stop the spread of COVID-19, i.e., lockdown and curfew, they also posed risk to the economy; in such a scenario, an analysis on how to strike a balance becomes urgent. Our research leverages the mobility big data from the University of Maryland COVID-19 Impact Analysis Platform and employs the Generalized Additive Model (GAM), to understand how the social demographic variables, NPTs (Non-Pharmaceutical Treatments) and PTs (Pharmaceutical Treatments) affect the New Death Rate (NDR) at county-level. We also portray the mutual and interactive effects of NPTs and PTs on NDR. Our results show that there exists a specific usage rate of PTs where its marginal effect starts to suppress the NDR growth, and this specific rate can be reduced through implementing the NPTs.

Indexed as

Models, StatisticalSARS-CoV-2AgedAged, 80 and overAge FactorsAntiviral AgentsCommunicable Disease ControlCOVID-19COVID-19 Drug TreatmentFemaleHumansLinear ModelsMaleMiddle AgedPandemicsTreatment OutcomeAntiviral Agents

Identifiers

PMID34634078
PMCPMC8504736
OpenAlexW3207638400

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.